Wasatch Advisors Inc. cut its position in Walgreens Boots Alliance Inc (NASDAQ:WBA) by 46.1% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 26,029 shares of the pharmacy operator’s stock after selling 22,225 shares during the quarter. Wasatch Advisors Inc.’s holdings in Walgreens Boots Alliance were worth $1,890,000 at the end of the most recent reporting period.
A number of other large investors have also recently bought and sold shares of the stock. Hudock Capital Group LLC grew its stake in Walgreens Boots Alliance by 0.5% in the 2nd quarter. Hudock Capital Group LLC now owns 1,306 shares of the pharmacy operator’s stock valued at $102,000 after buying an additional 6 shares during the last quarter. Northern Capital Management LLC grew its stake in Walgreens Boots Alliance by 0.4% in the 2nd quarter. Northern Capital Management LLC now owns 6,635 shares of the pharmacy operator’s stock valued at $520,000 after buying an additional 25 shares during the last quarter. MAI Capital Management grew its stake in Walgreens Boots Alliance by 0.6% in the 2nd quarter. MAI Capital Management now owns 5,272 shares of the pharmacy operator’s stock valued at $413,000 after buying an additional 34 shares during the last quarter. Truepoint Inc. grew its stake in Walgreens Boots Alliance by 0.5% in the 2nd quarter. Truepoint Inc. now owns 8,614 shares of the pharmacy operator’s stock valued at $698,000 after buying an additional 39 shares during the last quarter. Finally, Girard Partners LTD. boosted its holdings in Walgreens Boots Alliance by 1.9% in the 2nd quarter. Girard Partners LTD. now owns 3,053 shares of the pharmacy operator’s stock valued at $239,000 after purchasing an additional 56 shares during the period. Institutional investors and hedge funds own 61.20% of the company’s stock.
In other news, Director John Anthony Lederer purchased 20,000 shares of the business’s stock in a transaction that occurred on Thursday, October 26th. The stock was purchased at an average cost of $67.00 per share, with a total value of $1,340,000.00. Following the acquisition, the director now directly owns 50,000 shares of the company’s stock, valued at approximately $3,350,000. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director William C. Foote sold 2,736 shares of Walgreens Boots Alliance stock in a transaction dated Thursday, November 2nd. The shares were sold at an average price of $67.37, for a total transaction of $184,324.32. Following the transaction, the director now directly owns 16,415 shares of the company’s stock, valued at $1,105,878.55. The disclosure for this sale can be found here. Company insiders own 14.80% of the company’s stock.
Walgreens Boots Alliance Inc (NASDAQ:WBA) opened at $76.47 on Friday. The company has a market cap of $75,290.84, a PE ratio of 14.39, a PEG ratio of 1.28 and a beta of 1.22. Walgreens Boots Alliance Inc has a 1-year low of $63.82 and a 1-year high of $88.00. The company has a current ratio of 0.96, a quick ratio of 0.47 and a debt-to-equity ratio of 0.48.
Walgreens Boots Alliance (NASDAQ:WBA) last released its quarterly earnings data on Thursday, January 4th. The pharmacy operator reported $1.28 EPS for the quarter, topping analysts’ consensus estimates of $1.27 by $0.01. The company had revenue of $30.74 billion during the quarter, compared to the consensus estimate of $30.39 billion. Walgreens Boots Alliance had a net margin of 3.19% and a return on equity of 19.15%. The firm’s revenue for the quarter was up 7.9% compared to the same quarter last year. During the same period last year, the firm earned $1.10 EPS. research analysts anticipate that Walgreens Boots Alliance Inc will post 5.71 earnings per share for the current fiscal year.
Walgreens Boots Alliance declared that its Board of Directors has initiated a stock repurchase plan on Wednesday, October 25th that permits the company to buyback $1.00 billion in shares. This buyback authorization permits the pharmacy operator to purchase shares of its stock through open market purchases. Shares buyback plans are often a sign that the company’s leadership believes its stock is undervalued.
The company also recently declared a quarterly dividend, which will be paid on Monday, March 12th. Investors of record on Thursday, February 15th will be issued a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a yield of 2.09%. The ex-dividend date is Wednesday, February 14th. Walgreens Boots Alliance’s dividend payout ratio is currently 44.20%.
TRADEMARK VIOLATION WARNING: This report was first posted by Week Herald and is the property of of Week Herald. If you are reading this report on another publication, it was stolen and reposted in violation of United States and international trademark and copyright law. The original version of this report can be viewed at https://weekherald.com/2018/01/20/wasatch-advisors-inc-has-1-89-million-stake-in-walgreens-boots-alliance-inc-wba.html.
Walgreens Boots Alliance Company Profile
Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).
Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc (NASDAQ:WBA).
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.